Description

SLU-PP-332 – 500mcg

(PPARδ/PPARβ Modulator – Experimental Small Molecule)

SLU-PP-332 is an experimental small molecule investigated as a selective modulator of peroxisome proliferator-activated receptor delta/beta (PPARδ/β). PPARδ is a nuclear receptor that regulates genes involved in fatty acid oxidation, glucose metabolism, mitochondrial biogenesis, and endurance adaptations. By modulating PPARδ activity, SLU-PP-332 has been studied in preclinical settings for its role in energy homeostasis, exercise-mimetic pathways, and potential therapeutic exploration in metabolic disorders.

---

Mechanism of Action (Based on Preclinical Research):

• Selectively binds and activates PPARδ/β nuclear receptors

• Upregulates genes associated with fatty acid transport and oxidation

• Promotes mitochondrial biogenesis and oxidative muscle fiber adaptation

• Enhances endurance-like metabolic signatures without direct exercise stimulus

---

Potential Benefits (Based on Preclinical Research):

• Studied for improvements in lipid metabolism and fatty acid oxidation

• Investigated for enhanced endurance and exercise-mimetic effects in animal models

• Potential applications in obesity, insulin resistance, and metabolic disease research

• Explored for mitochondrial support and cellular energy regulation

---

For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory agency and is intended solely for laboratory research.